Fundz

Proscia raised $50M in funding led by Insight Partners to grow its customer footprint and advance its Concentriq platform’s AI capabilities.

RECENTLY ACQUIREDMar 19, 2025

Amount Raised

$50 Million

Round Type

Funding Round

PhiladelphiaInformation TechnologySoftware

Investors

Emerald Development ManagersAvenue Venture Opportunities FundGPG HealthcareAI Capital PartnersTriangle Peak PartnersFusion FundInterwoven VenturesRazor's EdgeInsight Partners

Description

Proscia, a Philadelphia-based software company improving pathology’s transition to digital and AI, raised $50M in funding. The round, which brought the total amount to $130M, was led by Insight Partners along with AI Capital Partners and Triangle Peak Partners. Other investors included Avenue Venture Opportunities Fund, Emerald Development Managers, GPG Healthcare, Fusion Fund, Interwoven Ventures, and Razor’s Edge. The funds will be used to enhance the company's offerings and expand its market presence.

Who to call at Proscia, and when

A new round usually means Proscia is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Proscia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Proscia, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Proscia

Location

1700 MARKET STREET

Philadelphia, Pennsylvania, United States

About

Proscia is a software company accelerating pathology’s transition to a digital, data-driven discipline and enabling AI to advance precision medicine. Its Concentriq enterprise pathology platform, precision medicine AI portfolio, and real-world data fuel the development and use of novel therapies and diagnostics to drive the fight against humanity’s most challenging diseases, like cancer. 16 of the top 20 pharmaceutical companies and a global network of diagnostic laboratories rely on Proscia’s solutions each day. The company has FDA 510(k) clearance and CE-IVDR certification for its diagnostic software.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Proscia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsColeman S., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Proscia's next move

See what Strategic adds

Proscia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.